Related Topics
Breakthrough SARS-CoV-2 cases clear more quickly, less likely to spread infection over time
People who are vaccinated for SARS-CoV-2 but get breakthrough infections may be less likely to spread the virus because they shed it for a shorter period than unvaccinated people who are infected, according a new study led by…
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity, according to a new study.
Better data, better health
CAUSALab investigates how to use data to support better decisions in medicine, public health, and policy.
How to gather safely this Thanksgiving
The top three ways to stay safe from COVID-19 if you’re gathering indoors with family and friends this Thanksgiving are to be vaccinated, to make sure the space is ventilated, and to take a rapid test the morning…
Symposium explores health lessons learned from the pandemic
The John B. Little Symposium focused on lessons learned from the COVID-19 pandemic and how to better apply them to the next major disease outbreak.
Vaccine researcher Kizzmekia Corbett wins top honor for federal service
Harvard Chan School's Kizzmekia Corbett has been named a “Federal Employee of the Year” for conducting groundbreaking vaccine research while working at the National Institutes of Health.
How to pick which booster shot to get
Harvard Chan School's Asaf Bitton offered advice on choosing a COVID-19 vaccine booster.
WHO’s historic recommendation for malaria vaccine spurs hope
The long and at times faltering fight against malaria hit a turning point this week when the World Health Organization (WHO) recommended a broad rollout of a vaccine that protects against Plasmodium falciparum, the deadliest malaria parasite globally…
Clear communication key to fostering trust in COVID-19 guidance
Harvard Chan School's Jay Winsten offers a critique of recent communications about COVID-19 boosters, as well as advice on how health officials can improve their messaging.
Kizzmekia Corbett is just getting started
She played a key role in developing the Moderna COVID-19 vaccine. Now at the Harvard Chan School, she’s turning to the pathogens that may spark the next pandemic.